Open AccessThe impact of vedolizumab on COVID-19 outcomes among adult IBD patients in the SECURE-IBD registry
Author(s) -
Manasi Agrawal,
Xian Zhang,
Erica J. Brenner,
Ryan C. Ungaro,
Michael Kappelman,
Jean–Frédéric Colombel
Publication year - 2021
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/svtt-eh21
Subject(s) - vedolizumab , medicine , covid-19 , virology , inflammatory bowel disease , disease , infectious disease (medical specialty) , outbreak